Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 764 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Washington D.C. DC, Neptune City NJ, Vienna VA,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

for
Growth Hormone Deficiency
Location: Washington D.C. DC, Norfolk VA, Morristown NJ,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 0+

Code: NCT05820672

Recruiting

Post-Procedural Manual Manipulation for Infant Ankyloglossia

for
Ankyloglossia, Breastfeeding Support
Location: Washington DC
Sponsor: Georgetown University

Sex: All

Age: 0

Code: NCT06830148

Recruiting

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

for
Thymoma, Thymic Carcinoma
Location: Washington D.C. DC, Hackensack NJ, Chicago IL,
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT06248515

Phase2, Recruiting

Phase IB/II of CPX-351 for Relapse Prevention in AML

for
Acute Myeloid Leukemia (AML) in Remission
Location: Washington D.C. DC, Philadelphia PA, Hackensack NJ
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT04990102

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase3, Recruiting

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

for
Solid Tumor, MET Alteration
Location: Washington D.C. DC, Canton OH, Nashville TN
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT06669117

Phase1, Phase2, Recruiting

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

for
Solid Tumors, GI Cancer
Location: Washington DC, Baltimore MD, Durham NC, Boston MA,
Sponsor: Curegenix Inc.

Sex: All

Age: 18+

Code: NCT02675946

Phase1, Recruiting

Evaluating Novel Therapies in ctDNA Positive GI Cancers

for
Colon Adenocarcinoma, Rectal Adenocarcinoma,
Location: Washington D.C. DC, Hackensack NJ
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT05482516

Phase3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Washington D.C. DC, Arlington VA, Fairfax VA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

Addressing Genomic Disparities in Cancer Survivors

for
Hereditary Cancer, Genetic Testing
Location: Washington D.C. DC, New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT06073626

Recruiting

MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

for
Prostate Cancer, Localized Prostate Carcinoma
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: Male

Age: 18+

Code: NCT07644598

Phase2, Recruiting

Circulating Tumor DNA

for
ER+ Breast Cancer
Location: Washington D.C. DC, The Bronx NY, New Haven CT,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06923527

Phase2, Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase2, Recruiting

Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies

for
Cancer
Location: Washington DC, Louisville KY, Houston TX,
Sponsor: Advanced Cancer Therapeutics

Sex: All

Age: 18+

Code: NCT02044861

Phase1, Recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

for
Patients With Non-Small Cell Lung Cancer
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: OSE Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06472245

Phase3, Recruiting

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features

for
Non-small Cell Lung Cancer Stage III
Location: Washington D.C. DC, Charlottesville VA, St Louis MO
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT06449313

Phase2, Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

for
Early Breast Cancer
Location: Washington D.C. DC, Silver Spring MD, Baltimore MD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05827081

Phase3, Recruiting

Measuring Impact of Computer Gaming on Arm Use in Rett Syndrome

for
Rett Syndrome
Location: Washington DC
Sponsor: Georgetown University

Sex: All

Age: 4 - 60

Code: NCT05012475

Recruiting

Mosaic Trial for Stem Cell Transplant Recipients

for
Hematologic Malignancy, Stem Cell Transplant,
Location: Washington D.C. DC, Nutley NJ, Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06960993

Recruiting